<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34935599</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2222-1751</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emerging microbes &amp; infections</Title>
          <ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cryo-EM structure of <i>Mycobacterium tuberculosis</i> 50S ribosomal subunit bound with clarithromycin reveals dynamic and specific interactions with macrolides.</ArticleTitle>
        <Pagination>
          <StartPage>293</StartPage>
          <EndPage>305</EndPage>
          <MedlinePgn>293-305</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2021.2022439</ELocationID>
        <Abstract>
          <AbstractText>Tuberculosis (TB) is the leading infectious disease caused by <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>). Clarithromycin (CTY), an analog of erythromycin (ERY), is more potent against multidrug-resistance (MDR) TB. ERY and CTY were previously reported to bind to the nascent polypeptide exit tunnel (NPET) near peptidyl transferase center (PTC), but the only available CTY structure in complex with <i>D. radiodurans</i> (<i>Dra</i>) ribosome could be misinterpreted due to resolution limitation. To date, the mechanism of specificity and efficacy of CTY for <i>Mtb</i> remains elusive since the <i>Mtb</i> ribosome-CTY complex structure is still unknown. Here, we employed new sample preparation methods and solved the <i>Mtb</i> ribosome-CTY complex structure at 3.3Å with cryo-EM technique, where the crucial gate site A2062 (<i>E. coli</i> numbering) is located at the CTY binding site within NPET. Two alternative conformations of A2062, a novel <i>syn</i>-conformation as well as a swayed conformation bound with water molecule at interface, may play a role in coordinating the binding of specific drug molecules. The previously overlooked C-H hydrogen bond (H-bond) and π interaction may collectively contribute to the enhanced binding affinity. Together, our structure data provide a structural basis for the dynamic binding as well as the specificity of CTY and explain of how a single methyl group in CTY improves its potency, which provides new evidence to reveal previously unclear mechanism of translational modulation for future drug design and anti-TB therapy. Furthermore, our sample preparation method may facilitate drug discovery based on the complexes with low water solubility drugs by cryo-EM technique.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Wen</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">0000-0002-4973-1168</Identifier>
            <AffiliationInfo>
              <Affiliation>Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Fudan University Pudong Medical Center, Department of Systems Biology for Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>ZhiFei</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Membrane Biology, National Biomedical Imaging Center, Peking-Tsinghua Center for Life Sciences, School of Life Sciences, Peking University, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>China National Center for Biotechnology Development, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Yufan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Microbiology, Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cui</LastName>
            <ForeName>Peng</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liang</LastName>
            <ForeName>Jianhua</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xing</LastName>
            <ForeName>Qinghe</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Yanhui</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Wenhong</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Ying</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bio-X Institute, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Ning</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0003-3067-9993</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Membrane Biology, National Biomedical Imaging Center, Peking-Tsinghua Center for Life Sciences, School of Life Sciences, Peking University, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Emerg Microbes Infect</MedlineTA>
        <NlmUniqueID>101594885</NlmUniqueID>
        <ISSNLinking>2222-1751</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018942">Macrolides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>H1250JIK0A</RegistryNumber>
          <NameOfSubstance UI="D017291">Clarithromycin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D017291" MajorTopicYN="N">Clarithromycin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020285" MajorTopicYN="N">Cryoelectron Microscopy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018942" MajorTopicYN="N">Macrolides</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009169" MajorTopicYN="Y">Mycobacterium tuberculosis</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054657" MajorTopicYN="N">Ribosome Subunits</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">50S ribosomal subunit</Keyword>
        <Keyword MajorTopicYN="N">Cryo-EM</Keyword>
        <Keyword MajorTopicYN="N">Mycobacterium tuberculosis</Keyword>
        <Keyword MajorTopicYN="N">clarithromycin</Keyword>
        <Keyword MajorTopicYN="N">dynamic interaction</Keyword>
        <Keyword MajorTopicYN="N">gate site a2062</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>22</Day>
          <Hour>12</Hour>
          <Minute>32</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34935599</ArticleId>
        <ArticleId IdType="pmc">PMC8786254</ArticleId>
        <ArticleId IdType="doi">10.1080/22221751.2021.2022439</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>WHO . Global tuberculosis report. 2021. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson DN.
Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat Rev Microbiol. 2014;12(1):35–48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24336183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adeniji AA, Knoll KE, Loots DT.. 
Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus. Appl Microbiol Biotechnol. 2020;104(13):5633–5662.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32372202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van der Paardt AL, et al. . 
Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis. Eur Respir J. 2017;49(3).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28331034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun F, et al. . 
Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study. Eur Respir J. 2019;53(3).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30578402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daley CL, et al. . 
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis. 2020;71(4):e1–e36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7768748</ArticleId>
            <ArticleId IdType="pubmed">32628747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandes PB, et al. . 
In vitro and in vivo activities of clarithromycin against mycobacterium avium. Antimicrob Agents Chemother. 1989;33(9):1531–1534.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC172696</ArticleId>
            <ArticleId IdType="pubmed">2530933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dubois J, St-Pierre C.. 
In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against legionella species. Diagn Microbiol Infect Dis. 1999;33(4):261–265.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10212753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morimoto S, et al. . 
Chemical modification of erythromycins. II. Synthesis and antibacterial activity of O-alkyl derivatives of erythromycin A. J Antibiot (Tokyo). 1990;43(3):286–294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2324013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu ZHJ, et al. . 
Structure-activity relationships of macrolides against mycobacterium tuberculosis. Tuberculosis. 2008;88:S49–S63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18762153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Falzari K, et al. . 
In vitro and in vivo activities of macrolide derivatives against mycobacterium tuberculosis. Antimicrob Agents Chemother. 2005;49(4):1447–1454.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1068601</ArticleId>
            <ArticleId IdType="pubmed">15793125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eyal Z, et al. . 
Structural insights into species-specific features of the ribosome from the pathogen staphylococcus aureus. Proc Natl Acad Sci U S A. 2015;112(43):E5805–E5814.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4629319</ArticleId>
            <ArticleId IdType="pubmed">26464510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kannan K, Mankin AS.. 
Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action. Ann N Y Acad Sci. 2011;1241:33–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22191525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bulkley D, et al. . 
Revisiting the structures of several antibiotics bound to the bacterial ribosome. Proc Natl Acad Sci U S A. 2010;107(40):17158–17163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2951403</ArticleId>
            <ArticleId IdType="pubmed">20876130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schlunzen F, et al. . 
Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature. 2001;413(6858):814–821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11677599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunkle JA, et al. . 
Structures of the escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action. Proc Natl Acad Sci U S A. 2010;107(40):17152–17157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2951456</ArticleId>
            <ArticleId IdType="pubmed">20876128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson DN, et al. . 
Species-specific antibiotic-ribosome interactions: implications for drug development. Biol Chem. 2005;386(12):1239–1252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16336118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Douthwaite S.
Designer drugs for discerning bugs. Proc Natl Acad Sci U S A. 2010;107(40):17065–17066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2951416</ArticleId>
            <ArticleId IdType="pubmed">20876111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kannan K, Vazquez-Laslop N, Mankin AS.. 
Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel. Cell. 2012;151(3):508–520.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23101624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hentschel J, et al. . 
The complete structure of the mycobacterium smegmatis 70S ribosome. Cell Rep. 2017;20(1):149–160.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28683309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang K, et al. . 
Structural insights into species-specific features of the ribosome from the human pathogen Mycobacterium tuberculosis. Nucleic Acids Res. 2017;45(18):10884–10894.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5737476</ArticleId>
            <ArticleId IdType="pubmed">28977617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Z, et al. . 
Cryo-EM structure of mycobacterium smegmatis ribosome reveals two unidentified ribosomal proteins close to the functional centers. Protein Cell. 2018;9(4):384–388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5876184</ArticleId>
            <ArticleId IdType="pubmed">28875450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mishra S, et al. . 
Structures of mycobacterium smegmatis 70S ribosomes in complex with HPF, tmRNA, and P-tRNA. Sci Rep. 2018;8(1):13587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6133939</ArticleId>
            <ArticleId IdType="pubmed">30206241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halfon Y, et al. . 
Exit tunnel modulation as resistance mechanism of S. aureus erythromycin resistant mutant. Sci Rep. 2019;9(1):11460.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6685948</ArticleId>
            <ArticleId IdType="pubmed">31391518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Svetlov MS, et al. . 
High-resolution crystal structures of ribosome-bound chloramphenicol and erythromycin provide the ultimate basis for their competition. Rna. 2019;25(5):600–606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6467010</ArticleId>
            <ArticleId IdType="pubmed">30733327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang L, et al. . 
Allosteric control of the ribosome by small-molecule antibiotics. Nat Struct Mol Biol. 2012;19(9):957–963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3645490</ArticleId>
            <ArticleId IdType="pubmed">22902368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, et al. . 
Electron counting and beam-induced motion correction enable near-atomic-resolution single-particle cryo-EM. Nat Methods. 2013;10(6):584–590.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3684049</ArticleId>
            <ArticleId IdType="pubmed">23644547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mindell JA, Grigorieff N.. 
Accurate determination of local defocus and specimen tilt in electron microscopy. J Struct Biol. 2003;142(3):334–347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12781660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheres SH.
RELION: implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol. 2012;180(3):519–530.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3690530</ArticleId>
            <ArticleId IdType="pubmed">23000701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Emsley P, et al. . 
Features and development of coot. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 4):486–501.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2852313</ArticleId>
            <ArticleId IdType="pubmed">20383002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adams PD, et al. . 
PHENIX: a comprehensive python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66:213–221.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2815670</ArticleId>
            <ArticleId IdType="pubmed">20124702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen VB, et al. . 
Molprobity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 1):12–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2803126</ArticleId>
            <ArticleId IdType="pubmed">20057044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morimoto S, et al. . 
Chemical modification of erythromycins. V. Synthesis and antibacterial activity of 4''-O-methyl derivatives of erythromycin a 11,12-cyclic carbonate. J Antibiot (Tokyo). 1990;43(5):566–569.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2358407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Svetlov MS, et al. . 
Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance. Nat Chem Biol. 2021;17(4):412–420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7990689</ArticleId>
            <ArticleId IdType="pubmed">33462493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Westhof E, Fritsch V.. 
RNA folding: beyond watson-Crick pairs. Structure. 2000;8(3):R55–R65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10745012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalra K, et al. . 
Occurrence and stability of lone pair-π and OH-π interactions between water and nucleobases in functional RNAs. Nucleic Acids Res. 2020;48(11):5825–5838.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7293021</ArticleId>
            <ArticleId IdType="pubmed">32392301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawai S, et al. . 
Direct quantitative measurement of the C═O⋅⋅⋅H-C bond by atomic force microscopy. Sci Adv. 2017;3(5):e1603258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5429039</ArticleId>
            <ArticleId IdType="pubmed">28508080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mougari F, et al. . 
Selection of resistance to clarithromycin in Mycobacterium abscessus subspecies. Antimicrob Agents Chemother. 2017;61(1).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5192163</ArticleId>
            <ArticleId IdType="pubmed">27799212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furneri PM, et al. . 
Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of mycoplasma hominis. Antimicrob Agents Chemother. 2001;45(10):2958–2960.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC90764</ArticleId>
            <ArticleId IdType="pubmed">11557502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vázquez-Laslop N, et al. . 
The key function of a conserved and modified rRNA residue in the ribosomal response to the nascent peptide. Embo J. 2010;29(18):3108–3117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2944061</ArticleId>
            <ArticleId IdType="pubmed">20676057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramu H, et al. . 
Nascent peptide in the ribosome exit tunnel affects functional properties of the A-site of the peptidyl transferase center. Mol Cell. 2011;41(3):321–330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21292164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sothiselvam S, et al. . 
Macrolide antibiotics allosterically predispose the ribosome for translation arrest. Proc Natl Acad Sci U S A. 2014;111(27):9804–9809.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4103360</ArticleId>
            <ArticleId IdType="pubmed">24961372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen HL, et al. . 
Erythromycin, Cethromycin and Solithromycin display similar binding affinities to the E. coli's ribosome: A molecular simulation study. J Mol Graph Model. 2019;91:80–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31200217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beckert B, et al. . 
Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics. Nat Commun. 2021;12(1):4466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8298421</ArticleId>
            <ArticleId IdType="pubmed">34294725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vázquez-Laslop N, Mankin AS.. 
How macrolide antibiotics work. Trends Biochem Sci. 2018;43(9):668–684.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6108949</ArticleId>
            <ArticleId IdType="pubmed">30054232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kannan K, Vázquez-Laslop N, Mankin AS.. 
Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel. Cell. 2012;151(3):508–520.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23101624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin J, et al. . 
Ribosome-Targeting antibiotics: modes of action, mechanisms of resistance, and implications for drug design. Annu Rev Biochem. 2018;87:451–478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29570352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernández IS, et al. . 
Unusual base pairing during the decoding of a stop codon by the ribosome. Nature. 2013;500(7460):107–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3732562</ArticleId>
            <ArticleId IdType="pubmed">23812587</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
